Note that some links may require subscriptions.
Former White House Chief Medical Adviser and NIAID Director Anthony Fauci, MD, will join Georgetown University next month as a distinguished professor in the School of Medicine’s Division of Infectious Diseases, and will hold an additional appointment in the university’s McCourt School of Public Policy.
E-cigarettes are still “flooding the U.S.” and addicting teens. (KFF Health News)
An investigative report looks at the secretive world of penile enlargement. (ProPublica)
Five cases of malaria were confirmed in Florida and Texas over a period of 2 months, marking the first time the potentially fatal mosquito-borne disease was acquired locally in the U.S. in 20 years, according to the CDC. (Reuters)
A $5 billion federal program in the U.S. is aimed at making better COVID vaccines, but is short on key details. (New York Times)
And billions of dollars left from a plan to deliver COVID vaccines to the world’s poorest could be diverted for other pandemics or to support vaccine manufacturing in Africa. (Reuters)
In the U.K., the National Cancer Research Institute announced it will be winding down after 22 years.
And Polish officials are looking into an H5N1 avian flu link to cat deaths, according to the University of Minnesota.
A gonorrhea vaccine being developed by GSK received fast-track designation from the FDA. (Reuters)
UnitedHealth Group’s Optum agreed to acquire home health giant Amedisys. (STAT)
GSK settled its first Zantac cancer lawsuit due for trial in the U.S. (Reuters)
This is how a shortage of a $15 cancer drug is “upending treatment.” (New York Times)
A deadly Texas heat wave is spreading. (CNN)
In Charleston, South Carolina, a new museum “nods to historical roots” of health disparities in the U.S. (KFF Health News)
Former President George W. Bush’s AIDS-fighting program has been engulfed in the abortion wars. (Politico)
As older adults flock to pickleball, outpatient surgeries are rising amid what could amount to more than $350 million in game-related injuries in the U.S. this year. (Quartz)
And those looking for live entertainment could opt to see a cover band comprised of all-stars in the field of immunotherapy. (Wall Street Journal)
Please enable JavaScript to view the